Cite

Sustained efficacy and tolerability of onabotulinumtoxinA in naive and non-naive patients with cervical dystonia: Preliminary completer analysis from CD-PROBE.

MLA

Agarwal, Pinky, et al. “Sustained Efficacy and Tolerability of OnabotulinumtoxinA in Naive and Non-Naive Patients with Cervical Dystonia: Preliminary Completer Analysis from CD-PROBE.” Toxicon, vol. 190, Jan. 2021, pp. S1–2. EBSCOhost, https://doi.org/10.1016/j.toxicon.2020.11.342.



APA

Agarwal, P., Schwartz, M., Zuzek, A., & Patel, A. (2021). Sustained efficacy and tolerability of onabotulinumtoxinA in naive and non-naive patients with cervical dystonia: Preliminary completer analysis from CD-PROBE. Toxicon, 190, S1–S2. https://doi.org/10.1016/j.toxicon.2020.11.342



Chicago

Agarwal, Pinky, Marc Schwartz, Aleks Zuzek, and Atul Patel. 2021. “Sustained Efficacy and Tolerability of OnabotulinumtoxinA in Naive and Non-Naive Patients with Cervical Dystonia: Preliminary Completer Analysis from CD-PROBE.” Toxicon 190 (January): S1–2. doi:10.1016/j.toxicon.2020.11.342.